1. Home
  2. CERS vs RGP Comparison

CERS vs RGP Comparison

Compare CERS & RGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • RGP
  • Stock Information
  • Founded
  • CERS 1991
  • RGP 1996
  • Country
  • CERS United States
  • RGP United States
  • Employees
  • CERS N/A
  • RGP N/A
  • Industry
  • CERS EDP Services
  • RGP Business Services
  • Sector
  • CERS Technology
  • RGP Consumer Discretionary
  • Exchange
  • CERS Nasdaq
  • RGP Nasdaq
  • Market Cap
  • CERS 433.6M
  • RGP 343.7M
  • IPO Year
  • CERS 1997
  • RGP 2006
  • Fundamental
  • Price
  • CERS $2.02
  • RGP $9.56
  • Analyst Decision
  • CERS Buy
  • RGP Hold
  • Analyst Count
  • CERS 2
  • RGP 3
  • Target Price
  • CERS $3.25
  • RGP $13.00
  • AVG Volume (30 Days)
  • CERS 747.5K
  • RGP 315.0K
  • Earning Date
  • CERS 10-31-2024
  • RGP 10-02-2024
  • Dividend Yield
  • CERS N/A
  • RGP 5.86%
  • EPS Growth
  • CERS N/A
  • RGP N/A
  • EPS
  • CERS N/A
  • RGP 0.62
  • Revenue
  • CERS $169,984,000.00
  • RGP $632,801,000.00
  • Revenue This Year
  • CERS $15.25
  • RGP N/A
  • Revenue Next Year
  • CERS $10.89
  • RGP $14.46
  • P/E Ratio
  • CERS N/A
  • RGP $15.42
  • Revenue Growth
  • CERS 10.79
  • RGP N/A
  • 52 Week Low
  • CERS $1.21
  • RGP $9.53
  • 52 Week High
  • CERS $2.59
  • RGP $15.44
  • Technical
  • Relative Strength Index (RSI)
  • CERS 42.12
  • RGP 33.91
  • Support Level
  • CERS $2.20
  • RGP $10.08
  • Resistance Level
  • CERS $2.35
  • RGP $10.45
  • Average True Range (ATR)
  • CERS 0.12
  • RGP 0.25
  • MACD
  • CERS -0.03
  • RGP -0.03
  • Stochastic Oscillator
  • CERS 10.84
  • RGP 3.78

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

Share on Social Networks: